Results 51 to 60 of about 447 (114)

Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered. [PDF]

Cardiol J, 2021
Sanfilippo F, La Via L, Merola F, Astuto M.   +3 more
europepmc   +1 more source

Use of levosimendan in hemodynamic management of heart failure in two neonates with intracranial arteriovenous shunts: a case series. [PDF]

Ital J Pediatr, 2023
Landolfo F, Giliberti P, De Rose DU, Pugnaloni F, Santisi A, Columbo C, Martini L, Ronchetti MP, Di Chiara L, Toscano A, Gandolfo C, Dotta A, Capolupo I.   +12 more
europepmc   +1 more source

Comparison of dobutamine and levosimendan for treatment of sepsis-induced cardiac dysfunction: A protocol for systematic review and meta-analysis. [PDF]

Medicine (Baltimore), 2022
Guo J, Zhang X, Zhu Y, Cheng Q.
europepmc   +1 more source

Levosimendan vs. Intra-Aortic Balloon Pump in Coronary Artery Bypass Grafting: A Meta-Analysis. [PDF]

Braz J Cardiovasc Surg
Wang Y, Qu J, Sheng D, Sun X, Zhong L, Wu Y, Liang H.   +6 more
europepmc   +1 more source

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report. [PDF]

Cardiol J, 2022
Fox H, Gummert JF, Sommer P, Knabbe C, Sohns C.   +4 more
europepmc   +1 more source

Levosimendan in Cardiac Arrest (LeiCA): Protocol for a Randomized, Double-Blind, Phase II Clinical Trial. [PDF]

Acta Anaesthesiol Scand
Rysz S, Flam B, Hedberg M, Galmén K, Mårtensson J, Djärv T, Jonsson Fagerlund M.   +6 more
europepmc   +1 more source

Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis. [PDF]

Cardiol J, 2021
Jaguszewski MJ, Gasecka A, Targonski R, Filipiak KJ, Szarpak L.   +4 more
europepmc   +1 more source

Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. [PDF]

BMJ Open
Zhao GM, Zhao GM, Zhang H, Chen W, Zhou JX, Li HL.   +5 more
europepmc   +1 more source

Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry. [PDF]

ESC Heart Fail, 2023
Codina P, Dobarro D, de Juan-Bagudá J, De Frutos F, Lupón J, Bayes-Genis A, Gonzalez-Costello J, Spanish LEVO‐D registry Collaborators.   +7 more
europepmc   +1 more source

A Comment on the use of Levosimendan for the Management of Right Ventricular Dysfunction in Patients Undergoing Mitral Valve Surgery. [PDF]

Ann Card Anaesth
Shah D, Korfiotis D, Zimbler N.
europepmc   +1 more source